Trial intelligence / Profile preview

DHEA Replacement in Older Adults

NCT00182975Phase 3Completed

Sponsor
National Institute on Aging
Start
Sep 2002
Primary completion
Sep 2007
Modality
Allosteric Modulators
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in aging comparing DHEA Replacement with Placebo (2 arms). Primary endpoints: Body composition (truncal and visceral fat) at 12 months, Insulin resistance at 12 months and 2 more. Started Sep 2002; status: completed.

02

Drugs

dehydroepiandrosterone
03

Conditions

aging

Beyond the preview

Go deeper on NCT00182975.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00182975.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call